DRUG DELIVERY

1 . A wearable drug delivery device comprising:

a first housing comprising a stored energy source disposed within the first housing;

a second housing comprising a syringe movable within the second housing between a withdrawn position and an extended position, the syringe including a needle and a drug container in fluid communication with each other;

a flexible conductor connected between the first housing and the second housing, the flexible conductor configured to convey energy released from the stored energy source which moves the syringe from the withdrawn position to the extended position and extends the needle extending beyond the second housing.

2 . The wearable drug delivery device of claim 1 wherein the stored energy source is a spring and wherein the flexible conductor is a Bowden cable.

3 . The wearable drug delivery device of claim 1 wherein the stored energy source is a compressed gas and wherein the flexible conductor is a lumen.

4 . The wearable drug delivery device of claim 1 further comprising:

a release mechanism coupled to the stored energy source and configured to discharge stored energy; and

a trigger mechanism disposed at one end of the second housing and coupled to the release mechanism such that in response to the trigger mechanism being activated, the release mechanism discharges the stored energy.

5 . The wearable drug delivery device of claim 1 further comprising:

a release mechanism coupled to the stored energy source and configured to release stored energy; and

a trigger mechanism disposed at one end of the first housing and coupled to the release mechanism such that in response to the trigger mechanism being activated, the release mechanism discharges the stored energy.

6 . The wearable drug delivery device of claim 1 wherein the first housing further includes a first concave surface and the second housing includes a second concave surface opposite the first concave surface, each of the first and second concave surfaces extends along a longitudinal axis lying between the first housing and the second housing and has a concavity defined by a point along the longitudinal axis.

7 . The wearable drug delivery device of claim 6 wherein the first and second concave surfaces are configured to conform to the human wrist.

8 . The wearable drug delivery device of claim 1 further comprising:

a cover hingedly attached to the first housing and operable between an initial close position and final open position; and

an interlock in releaseable engagement with the cover such that when unlocked the cover swings from the initial close position to the final open position.

9 . The wearable drug delivery device of claim 8 wherein the interlock includes a recess defined by the first housing and a projection extending from the second housing, the interlock unlocks when the projection is inserted into the recess.

10 . The wearable drug delivery device of claim 1 wherein the drug container is filled with any one of epinephrine and insulin.

11 . The wearable drug delivery device of claim 1 wherein the second housing includes an open end through which the needle extends when the syringe is in the extended position; and

the wearable drug delivery device further comprising a seal at the open end for keeping the needle sterile when the syringe is in the withdrawn position.

12 . A wearable drug delivery device comprising:

a first housing including a first longitudinal axis and a first concave surface extending in the direction of the first longitudinal axis, the concavity of the first concave surface defined by a point along an axis offset and parallel to the first longitudinal axis, the first housing further including a stored energy source disposed within the first housing;

a first connector disposed at an end of the first housing;

a second housing including a second longitudinal axis and a second concave surface extending in the direction of the second longitudinal axis, the concavity of the second concave surface defined by a second point along an axis offset and parallel to the second longitudinal axis;

a syringe movable within the second housing between a withdrawn position and an extended position, the syringe including a needle and a drug container in fluid communication with each other;

a second connector disposed at an end of the second housing, the second connector adapted to couple the first connector of the first housing; and

a band releasably coupled to the first housing and the second housing, such that when coupled to the band, the first concave surface of the first housing is opposite the second concave surface of the second housing.

13 . The wearable drug delivery device of claim 12 wherein the stored energy source is any one of pre-compressed spring or compressed gas.

14 . The wearable drug delivery device of claim 12 wherein the first connector and the second connector are coaxially aligned with the first longitudinal axis and the second longitudinal axis, respectively.

15 . The wearable drug delivery device of claim 12 wherein the first connector is a recess defined in the end of the first housing and the second connector is a protrusion extending from the end of the second housing.

16 . The wearable drug delivery device of claim 15 wherein the recess includes radial slots and the protrusion includes radial tabs corresponding to the radial slots.

17 . The wearable drug delivery device of claim 12 wherein the first connector and the second connector, when connected, form a passageway between the first and second housings through which a driving pin slides and moves the syringe from the withdrawn position to the extended position; and wherein the needle extends beyond the second housing when the syringe is in the extended position.

18 . The wearable drug delivery device of claim 12 further comprising a trigger portion disposed at an end of the second housing opposite the second connector, the trigger portion when activated discharges stored energy, which, in turn, moves the syringe from the withdrawn position to the extended position; and wherein the needle extends beyond the second housing when the syringe is in the extended position.

19 . The wearable drug delivery device of claim 12 wherein the drug container is filled with any one of epinephrine and insulin.

20 . The wearable drug delivery device of claim 12 wherein the second housing includes an open end opposite the second connector through which the needle extends when the syringe is in the extended position; and

the wearable drug delivery device further comprising a seal at the open end for keeping the needle sterile when the syringe is in the withdrawn position.